NCT03997162Active, not recruiting
Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery
Gastric Cancer Enhanced Recovery After Surgery Pathway
Source: ClinicalTrials.gov · Last updated 22 Oct 2026
Brief summary (registry, in English)
This phase II trial studies how well an early recovery after surgery protocol works in enhancing quality of life in participants with stage 0-IIIC gastric cancer undergoing surgery. The early recovery after surgery protocol may decrease pain and nausea, promote bowl function, decrease the number of days hospitalized, and improve a participant's ability to function normally after surgery.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 52 (actual)
- First submitted
- 6 Aug 2018
- Start date
- 8 Jan 2019
- Primary completion date
- 18 Jan 2023
- Lead sponsor
- City of Hope Medical Center
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT03997162
What you commit to
- Study type: Observational
- Participants enrolled: 52
- From 8 Jan 2019 to the primary completion date, 18 Jan 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients will be excluded if they are not candidates for surgery
- Patients will be excluded from the study if they have had prior gastric surgery, with the exception of a gastrostomy tube.
Other
- Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.
Who the study is looking for
- Patients to be included are those with a biopsy proven diagnosis of gastric adenocarcinoma who are undergoing curative gastric surgery or prophylactic total gastrectomy for genetic risk.
- Patients with clinical stage 0-IIIC will be included.
- Any performance status and any life expectancy.
- The effects of gastric surgery on the developing fetus are unknown. For this reason, women of childbearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for six months following duration of study participation. Should a woman become pregnant or suspect that she is pregnant while participating on the trial, she should inform her treating physician immediately.
- All subjects must have the ability to understand and the willingness to sign a written informed consent.
- Prior therapy will not be used as a limitation in this study.
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| City of Hope Medical Center Coordinator of this site? Confirm its status | Duarte | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.